Fund Evaluator:
Hartford Healthcare R6 (HGHVX)
Follow This Fund
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Fund Details
Hartford Healthcare R6 Overview
Hartford Healthcare R6 (HGHVX) is an actively managed Sector Equity Health fund. Hartford Mutual Funds launched the fund in 2019.
The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
About Hartford Healthcare R6 (HGHVX)
There are 1 members of the management team with an average tenure of 5.92 years: Rebecca Sykes (2020). Management tenure is more important for actively managed funds than passive index funds.
The fund has 2 primary benchmarks: S&P 500 (TR) (1970) index with a weighting of 100% and S&P 1500 Health Care TR index with a weighting of 100%. Hartford Healthcare R6 has 85 securities in its portfolio. The top 10 holdings constitute 47.9% of the fund’s assets. The fund meets the SEC requirement of being classified as a diversified fund. The fund is not considered to have an ESG focus with its investment selection and management.
Hartford Healthcare R6 is part of the Equity global asset class and is within the Sector Equity fund group. Hartford Healthcare R6 has 3.6% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 93.5%. There is 3.6% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). Hartford Healthcare R6 has 3.0% of the portfolio in cash.
Assets Under Management
The fund has $6 million in total assets, which is below the $884 million average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
HGHVX Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The Hartford Healthcare R6 expense ratio is high compared to funds in the Health category. Hartford Healthcare R6 has an expense ratio of 0.94%, which is 22% lower than its category average, making the fund expense ratio grade a B. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. Hartford Healthcare R6 has a portfolio turnover rate of 40%, indicating that holds its assets around 0.0 years. By way of comparison, the average portfolio turnover is 61% for the Health category.
Recently, in the month of July 2026, Hartford Healthcare R6 returned -0.4%, which earned it a grade of B, as the Health category had an average return of -0.4%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all funds in that category.
Hartford Healthcare R6 has a trailing yield of 0.00%, which is below the 0.39% category average. The fund normally distributes its income annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
Hartford Healthcare R6 Grades
Year to date, the fund has returned 5.1%, 2.0 percentage points worse than the category, which translates into a grade of C. The fund has returned 32.7% over the past year (grade of B), 7.9% over the past three years (grade of D) and 2.6% per year over the past five years (grade of D) and 8.5% per year over the past 10 years (grade of D).
For more mutual fund grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about Hartford Healthcare R6, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
HGHVX Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| HGHVX Return (NAV) | -0.4% | 9.8% | 32.7% | 7.9% | 2.6% | 8.5% |
| HGHVX Grade | B | C | B | D | D | D |
| +/- Category | -0.0% | -0.8% | -1.2% | -2.8% | -2.4% | -0.8% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| HGHVX Tax Cost Ratio | na | na | 0.7% | 0.7% | 0.9% | na |
HGHVX Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| HGHVX Return (NAV) | 5.1% | 16.1% | 0.3% | 4.2% | -11.4% | 10.4% | 23.0% | 33.7% | -2.7% | 22.0% | -8.2% |
| HGHVX Grade | C | C | D | C | C | C | C | A | D | C | B |
| +/- Category | -2.0% | -4.5% | -2.2% | -1.4% | -2.0% | 1.6% | -1.4% | 5.3% | -3.0% | -1.4% | 2.7% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 14.9% |
| Total Risk Index: | 1.21 - Above Average |
| Category Risk Index: | 0.93 - Average |
| Category Risk Grade: | C (45% Rank) |
| Beta: | 0.60 |
| R-Squared: | 26% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 0.0% |
| Dividend Distribution: | Annually |
| Cap Gains Distribution: | |
| Total Assets: | $772 Mil |
| Fund Total Assets: | $ 7 Mil |
| Share Class Type: | Retirement |
| Portfolio Turnover: | 40% |
Management Team
| Number of Managers: 1 | |||
| Longest Tenure: 5.9 years | |||
| Average Tenure: 5.9 years | |||
| Managers (Year): Sykes Rebecca (2020) | |||
Portfolio Composition (as of 6/30/26)
| # of Holdings: | 85 |
| % in Top 10 Holdings: | 47.9% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 3.6% |
Portfolio Allocation |
|
| Domestic Stock: | 93.5% |
| Foreign Stock: | 3.6% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 3.0% |
Purchase Information
| Fund Family: | Hartford Mutual Funds |
| Phone Number: | 888-843-7824 |
| Website: | www.hartfordfunds.com |
| Status: | Open |
| Inception Date: | February 28, 2019 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.94% ( Rating : High ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | Hartford Healthcare Y |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
